Viewing Study NCT04579757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-04-30 @ 12:25 PM
Study NCT ID: NCT04579757
Status: TERMINATED
Last Update Posted: 2025-05-08
First Post: 2020-09-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Sponsor: Hutchmed
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Solid Tumor View
None Colorectal Cancer View
None Neuroendocrine Tumors View
None Small Cell Lung Cancer View
None Gastric Cancer View
None Soft Tissue Sarcoma View
None Anaplastic Thyroid Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None VEGF View
None PD-1 View